Weiwei Ning
Impact in
-
- Cancer Immunotherapy and Biomarkers
- Cytokine Signaling Pathways and Interactions
-
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
- Oncology 5
- Pancreatic and Hepatic Oncology Research 1
- Polyomavirus and related diseases 1
- Co-authors
- Jianjie Zhu (3 shared papers)Zeyi Liu (3 shared papers)Yuanyuan Zeng (3 shared papers)Cheng Chen (2 shared papers)Jian-An Huang (2 shared papers)Qiu‐Xia Qu (1 shared paper)Nan Zhang (1 shared paper)Hui Zeng (1 shared paper)
- Journals
- Surgical Endoscopy (1 paper)Scientific Reports (1 paper)Biomarkers in Medicine (1 paper)Toxicology and Applied Pharmacology (1 paper)Therapeutic Advances in Respiratory Disease (1 paper)
- Partner nations
- China
In The Last Decade
Weiwei Ning
14 papers receiving 383 citations
Peers
Comparison fields: 5 of 57
- Oncology 190
- Immunology 138
- Cancer Research 57
- Pulmonary and Respiratory Medicine 70
- Molecular Biology 92
Countries citing papers authored by Weiwei Ning
This map shows the geographic impact of Weiwei Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Ning more than expected).
Fields of papers citing papers by Weiwei Ning
This network shows the impact of papers produced by Weiwei Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Ning. The network helps show where Weiwei Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 257 | |
| 2 | 2017 | 36 | |
| 3 | 2020 | 34 | |
| 4 | 2016 | 26 | |
| 5 | 2020 | 10 | |
| 6 | 2021 | 5 | |
| 7 | 2023 | 4 | |
| 8 | 2024 | 3 | |
| 9 | 2023 | 3 | |
| 10 | 2022 | 2 | |
| 11 | 2023 | 2 | |
| 12 | 2023 | 1 | |
| 13 | 2020 | 1 | |
| 14 | 2024 | 1 | |
| 15 | 2024 | 0 |
About Weiwei Ning
Weiwei Ning is a scholar working on Oncology, Molecular Biology, Pulmonary and Respiratory Medicine, Infectious Diseases and Surgery, having authored 15 papers that have together received 385 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (2 papers), Pancreatic and Hepatic Oncology Research (1 paper), Amoebic Infections and Treatments (1 paper), Enhanced Recovery After Surgery (1 paper), Respiratory Support and Mechanisms (1 paper), Antifungal resistance and susceptibility (1 paper), Polyomavirus and related diseases (1 paper) and Fungal Infections and Studies (1 paper). The work is most often cited by research in Oncology (190 citations), Immunology (138 citations), Cancer Research (57 citations), Pulmonary and Respiratory Medicine (70 citations) and Molecular Biology (92 citations). Weiwei Ning has collaborated with scholars based in China. Frequent co-authors include Jianjie Zhu, Zeyi Liu, Yuanyuan Zeng, Cheng Chen, Jian-An Huang, Qiu‐Xia Qu, Nan Zhang, Hui Zeng, Wenwen Du and Wenwen Du. Their work appears in journals such as Surgical Endoscopy, Scientific Reports, Biomarkers in Medicine, Toxicology and Applied Pharmacology and Therapeutic Advances in Respiratory Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.